Approvals/TGA/PRAMI XR pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack

Approved

STANDARD

PRAMI XR pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2d769aae3eded910
Product Name: PRAMI XR pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack
Artg Id: 225611
Artg Name: PRAMI XR pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2015-06-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2d769aae3eded910

Type

Standard